Correction: Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis

PDF  |  How to cite

Oncotarget. 2018; 9:6658-6658. https://doi.org/10.18632/oncotarget.24255

Metrics: PDF 1872 views  |   ?  

Shufang Fu1,*, Xin Wen2,*, Fei Han3, Yin Long4 and Gaosi Xu1

1 Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
2 Grade 2013, School of Stomatology, Nanchang University, Nanchang, China
3 Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
4 Grade 2013, The Second Clinical Medical College of Nanchang University, Nanchang, China
* Co-first authors contributted equally to this work

Published: January 15, 2018

This article has been corrected: Dr. Fu and Dr. Xu citations have been changed to affiliation 1 and affiliation 5 is now deleted.

Original article: Oncotarget. 2017; 8:89364-89374. DOI: https://doi.org/10.18632/oncotarget.19382.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24255